Elutia Inc. Total Assets
Elutia Inc. total assets. Based on the latest financial reports, Elutia Inc. (ELUT) holds total assets worth $43.65 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Elutia Inc. market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Elutia Inc. (2018–2025)
Total assets of Elutia Inc. from 2018 to 2025. This chart illustrates how Elutia Inc.'s total assets have evolved over time, based on quarterly financial data. See Elutia Inc. (ELUT) share price today for real-time trading data and today's change.
Elutia Inc. - Asset Composition Analysis
Elutia Inc. Total Assets Breakdown (December 2025)
Elutia Inc. total assets breakdown as of December 2025. Elutia Inc.'s total assets of $43.65 Million consist of 89.5% current assets and 10.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 58.3% |
| Accounts Receivable | $14.58 Million | 23.4% |
| Inventory | $2.62 Million | 4.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.53 Million | 2.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Elutia Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ELUT working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elutia Inc.'s current assets represent 89.5% of total assets in 2025, an increase from 38.0% in 2018.
- Cash Position: Cash and equivalents constituted 58.3% of total assets in 2025, up from 5.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 23.4% of total assets.
Elutia Inc. Competitors by Total Assets
Key competitors of Elutia Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Elutia Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.77 | 0.59 | 1.74 |
| Quick Ratio | 1.64 | 0.45 | 1.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $16.17 Million | $-15.67 Million | $16.74 Million |
Elutia Inc. - Advanced Valuation Insights
This section examines the relationship between Elutia Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.25 |
| Latest Market Cap to Assets Ratio | 0.58 |
| Asset Growth Rate (YoY) | 72.6% |
| Total Assets | $62.35 Million |
| Market Capitalization | $35.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values Elutia Inc.'s assets below their book value (0.58x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Elutia Inc.'s assets grew by 72.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Elutia Inc. (2018–2025)
The table below shows the annual total assets of Elutia Inc. from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $62.35 Million | +72.59% |
| 2024-12-31 | $36.13 Million | -16.81% |
| 2023-12-31 | $43.43 Million | -36.92% |
| 2022-12-31 | $68.84 Million | +2.49% |
| 2021-12-31 | $67.17 Million | -18.89% |
| 2020-12-31 | $82.81 Million | +84.96% |
| 2019-12-31 | $44.77 Million | -6.22% |
| 2018-12-31 | $47.74 Million | -- |
About Elutia Inc.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDer… Read more